Literature DB >> 468700

Prolonged methacholine-induced bronchoconstriction in dogs.

J W Ramsdell, P F Georghiou.   

Abstract

We studied the effect of prolonged airways obstruction induced by extended cholinergic stimulation in five anesthetized, mechanically ventilated dogs. A continuous intravenous metacholine infusion was utilized to maintain pulmonary resistance (RL) at 200--1500% preinfusion levels for 13--23 h. At maximum RL (18.86 +/- 7.74 vs. 2.09 +/- 0.18 (mean +/- SD) cmH2O/ (L/S) PREINfusion; P less than 0.01), dynamic lung compliance (Cdyn) fell from 67.5 +/- 14.6 to 32.7 +/- 11.6 ml/cmH2O (P less than 0.005) and arterial partial pressure of oxygen (PaO2) fell modestly from 95.8 +/- 6.1 Torr preinfusion to 83.2 +/- 12.7 Torr (P less than 0.05). Tachyphylaxis to methacholine developed, requiring increases in infusion rates to maintain elevated RL. Abnormalities in lung function resolved promptly upon termination of the infusion. Two similarly instrumented control animals ventilated for 19 and 25 h without metacholine infusion had no change in RL, Cdyn, or PaO2. Histological examination of the lungs revealed no differences between infused and control animals. In spite of marked increases in RL, prolonged cholinergic stimulation produced only mild changes in gas exchange and no sustained changes in lung function or structure.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 468700     DOI: 10.1152/jappl.1979.47.2.418

Source DB:  PubMed          Journal:  J Appl Physiol Respir Environ Exerc Physiol        ISSN: 0161-7567


  2 in total

1.  Pulmonary resistance in dogs: a comparison of xenon with nitrous oxide.

Authors:  P Zhang; A Ohara; T Mashimo; H Imanaka; A Uchiyama; I Yoshiya
Journal:  Can J Anaesth       Date:  1995-06       Impact factor: 5.063

2.  Effects of the components of positive airway pressure on work of breathing during bronchospasm.

Authors:  Adelaida M Miro; Michael R Pinsky; Paul L Rogers
Journal:  Crit Care       Date:  2004-02-09       Impact factor: 9.097

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.